Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mucosal TLR2-activating protein-based vaccination induces potent pulmonary immunity and protection against SARS-CoV-2 in mice
Anneliese S. Ashhurst, Matt D. Johansen, Joshua W. C. Maxwell, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 21

Showing 21 citing articles:

Amphiphilic Block Copolymer Nanostructures as a Tunable Delivery Platform: Perspective and Framework for the Future Drug Product Development
Gaurav Sinsinbar, Anivind Kaur Bindra, Shaoqiong Liu, et al.
Biomacromolecules (2024) Vol. 25, Iss. 2, pp. 541-563
Closed Access | Times Cited: 14
TLRs: Innate Immune Sentries against SARS-CoV-2 Infection
Stefania Mantovani, Barbara Oliviero, Stefania Varchetta, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 9, pp. 8065-8065
Open Access | Times Cited: 29
Development of a novel multi-epitope mRNA vaccine candidate to combat HMPV virus
Shiyang Ma, Fei Zhu, Yizhong Xu, et al.
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Open Access | Times Cited: 10
Research Advances of Lipid Nanoparticles in the Treatment of Colorectal Cancer
Junyi Zhang, Kamran Ali, Jianwei Wang
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 6693-6715
Open Access | Times Cited: 6
Nanoplatform Based Intranasal Vaccines: Current Progress and Clinical Challenges
Ziyi Bai, Dandan Wan, Tianxia Lan, et al.
ACS Nano (2024) Vol. 18, Iss. 36, pp. 24650-24681
Open Access | Times Cited: 6
Broad immunity to SARS-CoV-2 variants of concern mediated by a SARS-CoV-2 receptor-binding domain protein vaccine
Georgia Deliyannis, Nicholas A. Gherardin, Chinn Yi Wong, et al.
EBioMedicine (2023) Vol. 92, pp. 104574-104574
Open Access | Times Cited: 13
Self-adjuvant multiepitope nanovaccine based on ferritin induced long-lasting and effective mucosal immunity against H3N2 and H1N1 viruses in mice
Jiaojiao Nie, Yong-Fei Zhou, Fan Ding, et al.
International Journal of Biological Macromolecules (2024) Vol. 259, pp. 129259-129259
Closed Access | Times Cited: 4
Australia’s COVID-19 vaccine journey: progress and future perspectives
James A. Triccas, Megan Steain
Microbiology Australia (2024)
Open Access | Times Cited: 4
Immunobiology of COVID-19: Mechanistic and therapeutic insights from animal models
Hong‐Yi Zheng, Tian‐Zhang Song, Yong‐Tang Zheng
动物学研究 (2024) Vol. 45, Iss. 4, pp. 747-766
Open Access | Times Cited: 4
Current status of mucosal vaccines against SARS-CoV2: a hope for protective immunity
Ileana García-Silva, Dania O. Govea‐Alonso, Sergio Rosales‐Mendoza
Expert Opinion on Biological Therapy (2023) Vol. 23, Iss. 2, pp. 207-222
Closed Access | Times Cited: 5
A novel therapeutic multiepitope vaccine based on oncoprotein E6 and E7 of HPV 16 and 18: An in silico approach
Sari Eka Pratiwi, Ysrafil Ysrafil, Mardhia Mardhia, et al.
Bioimpacts (2024) Vol. 14, pp. 27846-27846
Open Access | Times Cited: 1
Mucosal immunity in COVID-19: a comprehensive review
Saeed Awad M. Alqahtani
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Intranasal boosting with RBD-HR protein vaccine elicits robust mucosal and systemic immune responses
Li Chen, Wenyan Ren, Hong Lei, et al.
Genes & Diseases (2023) Vol. 11, Iss. 4, pp. 101066-101066
Open Access | Times Cited: 3
Single-cell transcriptomics reveals the pulmonary inflammation induced by inhalation of subway fine particles
Weilai Zhou, Wenke Yuan, Yuwei Chen, et al.
Journal of Hazardous Materials (2023) Vol. 463, pp. 132896-132896
Closed Access | Times Cited: 3
mRNA vaccines protect from the lung microvasculature injury and the capillary blood volume loss occurring in SARS-CoV-2 paucisymptomatic infections
Roberto W. Dal Negro, Paola Turco, Massimiliano Povero
Multidisciplinary Respiratory Medicine (2024) Vol. 19, Iss. Vol. 19 (2024)
Open Access
Intranasal Self-Adjuvanted Lipopeptide Vaccines Elicit High Antibody Titers and Strong Cellular Responses against SARS-CoV-2
Joshua W. C. Maxwell, S. Stockdale, Erica L. Stewart, et al.
ACS Infectious Diseases (2024) Vol. 10, Iss. 9, pp. 3419-3429
Closed Access
Coronavirus spike protein-based vaccines. Vaccine delivery systems
Akmal M. Asrorov, Mirzakamol S. Ayubov, Bin Tu, et al.
Medicine in Drug Discovery (2024), pp. 100198-100198
Open Access
The swarmable magnetic-driven nanorobots for facilitating trans- intestinal mucosal delivery of oral vaccines to enhance mucosal and systemic immune responses
Linghong Huang, Xinyuan Sun, Quan Zhang, et al.
Research Square (Research Square) (2024)
Open Access
SARS-CoV-2 spike-FLIPr fusion protein plus lipidated FLIPr protects against various SARS-CoV-2 variants in hamsters
Ming-Shu Hsieh, Chia-Wei Hsu, Hung‐Chun Liao, et al.
Journal of Virology (2024) Vol. 98, Iss. 2
Open Access
Intranasal delivery of a subunit protein vaccine provides protective immunity against JN.1 and XBB-lineage variants
Lei Hong, Weiqi Hong, H. J. Yang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access
Genomic surveillance identifies potential risk factors for SARS-CoV-2 transmission at a mid-sized university in a small rural town
Kimberly R. Andrews, Daniel D. New, Digpal Singh Gour, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 1
Page 1

Scroll to top